Title:
PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2021/200975
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition of 2-amino-2-[2-(4-heptyloxy-3-trifluoromethylphenyl)ethyl]propane-1,3-diol, or a salt thereof. The pharmaceutical composition exhibits excellent storage stability and can suppress generation of analogous substances. An excipient selected from among calcium hydrogen phosphate, calcium dihydrogen phosphate, sodium hydrogen phosphate, and sodium dihydrogen phosphate is used in the pharmaceutical composition.
Inventors:
MATSUMOTO HIDEAKI (JP)
YOSHIZAWA SHOGO (JP)
WAKEBAYASHI DAISUKE (JP)
YOSHIZAWA SHOGO (JP)
WAKEBAYASHI DAISUKE (JP)
Application Number:
PCT/JP2021/013580
Publication Date:
October 07, 2021
Filing Date:
March 30, 2021
Export Citation:
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
International Classes:
A61K31/137; A61K9/48; A61K47/02; A61K47/26; A61P37/06
Domestic Patent References:
| WO2007069712A1 | 2007-06-21 | |||
| WO2007069712A1 | 2007-06-21 |
Foreign References:
| JP2016155777A | 2016-09-01 | |||
| JP2002284679A | 2002-10-03 | |||
| US8809314B1 | 2014-08-19 | |||
| JP2020063606A | 2020-04-23 |
Attorney, Agent or Firm:
TAKASHIMA, Hajime (JP)
Download PDF:
Previous Patent: COATED FOAM AND METHOD FOR PRODUCING COATED FOAM
Next Patent: MONEY PROCESSING DEVICE
Next Patent: MONEY PROCESSING DEVICE